MedTrace Logo

Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section

NCT03257514 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2018-03-08

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of alpha lipoic acid on uterine scar healing after cesarean section by using saline contrast sonohysterography

Conditions

  • Cesarean Section; Dehiscence
  • Cesarean Scar Niche

Interventions

DRUG

alpha lipoic acid drug (thioctic acid acid)

Alpha lipoic acid has anti-inflammatory, antioxidant effects and plays a role in wound healing process.

DRUG

Placebo Oral Tablet

placebo oral drug have the same shape of thiotacid tablet

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-01-01
Completion
2018-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257514 on ClinicalTrials.gov